The 1 analysts offering 12-month price forecasts for Diffusion Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +423.70% increase from the last price of 0.38.
The current consensus among 1 polled investment analysts is to Hold stock in Diffusion Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.04
Reporting Date Mar 30
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.